As of 2024-12-12, the Fair Value of Combigene AB (COMBI.ST) is -9.22 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.34 SEK, the upside of Combigene AB is -494.13%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -17.60 | -29.38 | 20.96 | -6.16 | -35.67 | -13.57 |
| YoY growth | -33.90% | -66.92% | 171.35% | -129.37% | -479.27% | -107.62% |
| Market Cap (mil) | 46.33 |
| P/E | |
| Forward P/E |
| EPS | -1.84 |
| Avg earnings growth rate | -107.62% |
| TTM earnings | -36.52 |